Synthesis of new indirubin derivatives and their in vitro anticancer activity
- 11 Downloads
The opening of epoxy rings from (2′Z)-N-1-(oxiran-2-ylmethyl)indirubin (2) and (2′Z-3′E)-indirubin-3ʹ-[O-oxiran-2-ylmethyl)oxime] (6) with thiols gave 17 new derivatives of indirubin in good yields. Their structures were elucidated by 1D-, 2D-NMR and HRMS spectra. Screening for anticancer activity was performed with four human cancer cell lines: SW480, LU-1, HepG2 and HL-60 in comparison with indirubin, indirubin-3′-oxime and 6-mercaptopurine. The results showed that cytotoxic and anti-proliferative activities of five derivatives were found in the range of 1.35–19.24 µM. Among synthesized derivatives, 4f showed the strongest activity against all four tested cancer cell lines with IC50 values of 1.65, 2.21, 1.90 and 1.35 µM, respectively.
KeywordsIndirubin Indirubin-3′-oxime 6-mercaptopurine Cytotoxic
The authors gratefully acknowledge Vietnam-Russia Tropical Center and Vietnam Academy of Science and Technology (VAST) for financial support via project VAST.HTQT.BELARUS.04/15-16.
Compliance with ethical standards
Conflict of interest
The authors declare no conflicts of interest.
- Cuong NM, Thuy DTT, Ha NV, Tai BH (2007) Isolation of indirubin from the leaves of Strobilanthes cusia. J Sci Technol 45(3A):195–199Google Scholar
- Hoessel R, Leclerc S, Endicott JA, Nobel ME, Lawrie A, Tunnah P, Leost M, Damiens E, Marie D, Marko D, Niederberger E, Tang W, Eisenbrand G, Meijer L (1999) Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1:60–67. https://doi.org/10.1038/9035 CrossRefPubMedGoogle Scholar
- Jung ME, Byun BJ, Kim HM, Lee JY, Park JH, Lee N, Son YH, Choi SU, Yang KM, Kim SJ, Lee KH, Kim YC, Choi G (2016) Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening. Bioorganic Med Chem Lett 26:2719–2723. https://doi.org/10.1016/j.bmcl.2016.03.111 CrossRefGoogle Scholar
- Lectere S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, Greengard P, Biernard J, Wu YZ, Mandelkow EM, Eisenbrand G, Meijer L (2001) Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved abnormal tau phosphorylation in alzheimer’s disease. J Biol Chem 276:251–260. https://doi.org/10.1074/jbc.M002466200 CrossRefGoogle Scholar
- Meijer L, Skaltsounis AL, Magiatis P, Polychronopoulos P, Leost M, Ryan XP, Vonica CA, Brivanlou A, Dajani R, Crovace C, Tarricone C, Musacchio A, Roe SM, Pearl L, Greengard P (2003) GSK-3-Selective inhibitors derived from tyrian purple indirubins. Chem Biol 10:1255–1266. https://doi.org/10.1016/j.chembiol.2003.11.010 CrossRefPubMedGoogle Scholar
- Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83:757–766. https://doi.org/10.1093/jnci/83.11.757 CrossRefPubMedPubMedCentralGoogle Scholar
- Perrin DD, Armarego WLF (1988) Purification of Laboratory Chemical, 3rd edn. Pergamon Press, OxfordGoogle Scholar
- Raju GN, Prathyusha TG, Sowmya PL, Mounika SJ, Nadendla RR (2015) Synthesis, characterization and biological activity of some 1,3,4-oxadiazole derivatives with benzothiazole moiety. Der Pharmacia Sinica 6:1–8Google Scholar
- Sano M, Ichimaru Y, Kurita M, Hayashi E, Homma T, Saito H, Masuda S, Nemoto N, Hemmi A, Suzuki T, Miyairi S, Hao H (2017) Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3′-oxime and 5-methoxyindirubin 3′-oxime in vitro and in vivo. Can Lett 397:72–82. https://doi.org/10.1016/j.canlet.2017.03.031 CrossRefGoogle Scholar
- Stasiak N, Koch WK, Glowniak K (2014) Modern industrial and pharmacological applications of indigo dye and its derivatives—a review. Acta Poloniae Pharmaceutica Drug Research 71:215–221Google Scholar
- Vaughan JR (1957) Heterocyclic sulphonamides. US patent 2783240Google Scholar